Dr. Omar K. Siddiqi, MD

Dr. Siddiqi practices at Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System.

Dr. Siddiqi's NPI, 1508069816, was assigned on June 6, 2007. Dr. Siddiqi graduated from Washington University School of Medicine in 2007. Dr. Siddiqi holds Massachusetts license 243423.

Dr. Siddiqi's primary practice is Boston Medical Center, at 1 Boston Medical Center Place, Boston, MA 02118 in Suffolk County. The practice phone is (617) 638-8000.

Dr. Siddiqi's primary practice is Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System. The medical group on file is Boston University Medical Group (Boston University Internal Medicine Associates). Dmand AI also links Dr. Siddiqi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Siddiqi practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Siddiqi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Siddiqi's licenses on file in 2 states: Massachusetts and Pennsylvania.

CMS data shows 1,024 Medicare services from Dr. Siddiqi across 19 procedure codes in 2024, for 623 Medicare patients. Medicare paid $59,085 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 623 Medicare patients who saw Dr. Siddiqi in 2024. The largest group is 65 to 74, with 254 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Siddiqi's median patient age at 64, with 46% women.

In 2024, Dr. Siddiqi wrote 1,374 Medicare Part D claims for 167 patients. 53% of them were for generic drugs. CMS names the drug for 1,252 of them, across 21 drugs with 11 or more claims each, at $11,241,977 in total drug cost. In 2023, CMS named 941 claims across 21 drugs.

Dr. Siddiqi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Siddiqi as offering telehealth.

CMS Open Payments shows 20 general payments to Dr. Siddiqi from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Janssen Research & Development, LLC paid the most, $2,170.

Dr. Siddiqi graduated from Washington University School of Medicine in 2007.